StartUPDATES: New developments from healthcare startups
Check out new developments from Emulate, HealthMine, LuminDx, and more.
Emulate CEO shares the organ-chip maker’s vision to understand and predict drug response
Each Organ-Chip is a transparent, flexible microenvironment that contains two parallel chambers that can be configured to grow human cells from an organ of interest, such as the liver, kidney proximal tubule, intestine, lung and brain
Solving Healthcare’s Provider Data Problem Starts with Interoperability
Break down the silos. Take control of your provider data.
StartUPDATES: New developments from healthcare startups
Check out new developments from Kiio, HealthMine, Emulate and Bind Benefits.
StartUPDATES: New developments from healthcare startups
Read about new developments from Emulate, Cellino, Heru and more.
StartUPDATES: New developments from healthcare startups
Read about news from life science companies Emulate, Astrocyte Pharmaceuticals and Bone Health Technologies.
StartUPDATES: New developments from healthcare startups
Read news from healthcare startups including Outcomes4Me, Emulate, and more.
The Human Algorithm: What AI Can’t Replace in Pharma Engagement
At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch.
Emulate and FDA join forces to build a better model
The hope is that the company’s liver chip will predict toxicity in humans better than current cell-based and animal models.
Organ-on-a-chip startup Emulate raises $28.75M Series B
Emulate wants its technology to "operate as a plug-and-play system in the hands of product development teams at pharmaceutical, chemical, food and consumer products companies," CEO James Coon said in a statement.